Skip to main content

and
  1. Article

    Open Access

    Central nervous system complications in SARS-CoV-2-infected patients

    To investigate the clinical manifestations, treatment and prognosis of COVID-19-associated central nervous system (CNS) complications.

    Zhonggui Li, Danyu Lin, **aoshuang Xu, **aohuan Liu, Jieli Zhang in Journal of Neurology (2023)

  2. Article

    Open Access

    The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson’s Disease with Motor Fluctuations

    Levodopa remains the gold standard for the treatment of Parkinson’s disease, but its long-term use is associated with motor complications whose management is still a significant challenge. Safinamide is a mult...

    Qianqian Wei, Yuyan Tan, **yi Xu, Enxiang Tao, Zuneng Lu, ** Pan in CNS Drugs (2022)

  3. Article

    Open Access

    Evaluation of the reliability of the criteria for assessing prescription quality in Chinese hospitals among pharmacists in China

    The reliability of Criteria for Assessing Prescription Quality in Chinese Hospitals (CAPQCH) has never been rigorously verified. This study was designed to verify the reliability of the CAPQCH among pharmacist...

    **aofang Tan, Jun Zhang, Dongshi Gu, San Ran, Tongtong Gu in BMC Health Services Research (2022)

  4. No Access

    Article

    Rifampicin and Parkinson’s disease

    Rifampicin is a macrocyclic antibiotic used extensively for the treatment of Mycobacterium tuberculosis and other mycobacterial infections. Recently, it was discovered that rifampicin exhibits neuroprotective eff...

    Wei Bi, Lihong Zhu, **una **g, Yanran Liang, Enxiang Tao in Neurological Sciences (2013)